The aforementioned alterations predispose IUGR infants to impaired glucose homeostasis, insulin sensitivity and adipose tissue development, factors that are associated with coronary vascular disease, hypertension and diabetes mellitus in adulthood6,7. The gene discussed is INS; the disease is fetal growth restriction.